Search research articles
Contact Us
Filters
Showing results (461-470 of 515) with videos related to
Page
of 52
Sort By:
Cytotherapy
|
September 3, 2022
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease
Rutvij A Khanolkar, Gaurav Tripathi, Poonam Dharmani-Khan, et al.
Cancer Immunology, Immunotherapy : CII
|
March 8, 2020
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
Tali Voloshin, Noa Kaynan, Shiri Davidi, et al.
Plos One
|
December 19, 2013
Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge
Arun K Sasikala-Appukuttan, Hyeon O Kim, Nikilyn J Kinzel, et al.
Gastrointestinal Endoscopy
|
June 4, 2005
A prospective two-center study comparing wireless capsule endoscopy with intraoperative enteroscopy in patients with obscure GI bleeding
Dirk Hartmann, Harald Schmidt, Georg Bolz, et al.
Neuropharmacology
|
June 13, 2018
CNS distribution, signalling properties and central effects of G-protein coupled receptor 4
P S Hosford, V Mosienko, K Kishi, et al.
Frontiers in Oncology
|
April 5, 2021
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond
Michael Orth, Valerie Albrecht, Karin Seidl, et al.
Cancers
|
June 24, 2022
Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma <i>In Vitro</i> and <i>In Vivo</i>
Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Cancers
|
February 25, 2023
Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma <i>In Vitro</i> and <i>In Vivo</i>. <i>Cancers</i> 2022, <i>14</i>, 2959
Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Journal of Medicinal Chemistry
|
January 26, 2008
Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors
Ester Muraglia, Olaf Kinzel, Cristina Gardelli, et al.
Nutrients
|
August 12, 2022
Omega-9 Modifies Viscoelasticity and Augments Bone Strength and Architecture in a High-Fat Diet-Fed Murine Model
Mahmoud Omer, Hessein Ali, Nina Orlovskaya, et al.
Page
of 52
Search research articles
Search
Showing results (461-470 of 515) with videos related to
Sort By:
Page
of 52
Cytotherapy
|
September 3, 2022
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease
Rutvij A Khanolkar, Gaurav Tripathi, Poonam Dharmani-Khan, et al.
Cancer Immunology, Immunotherapy : CII
|
March 8, 2020
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
Tali Voloshin, Noa Kaynan, Shiri Davidi, et al.
Plos One
|
December 19, 2013
Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge
Arun K Sasikala-Appukuttan, Hyeon O Kim, Nikilyn J Kinzel, et al.
Gastrointestinal Endoscopy
|
June 4, 2005
A prospective two-center study comparing wireless capsule endoscopy with intraoperative enteroscopy in patients with obscure GI bleeding
Dirk Hartmann, Harald Schmidt, Georg Bolz, et al.
Neuropharmacology
|
June 13, 2018
CNS distribution, signalling properties and central effects of G-protein coupled receptor 4
P S Hosford, V Mosienko, K Kishi, et al.
Frontiers in Oncology
|
April 5, 2021
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond
Michael Orth, Valerie Albrecht, Karin Seidl, et al.
Cancers
|
June 24, 2022
Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma <i>In Vitro</i> and <i>In Vivo</i>
Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Cancers
|
February 25, 2023
Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma <i>In Vitro</i> and <i>In Vivo</i>. <i>Cancers</i> 2022, <i>14</i>, 2959
Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Journal of Medicinal Chemistry
|
January 26, 2008
Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors
Ester Muraglia, Olaf Kinzel, Cristina Gardelli, et al.
Nutrients
|
August 12, 2022
Omega-9 Modifies Viscoelasticity and Augments Bone Strength and Architecture in a High-Fat Diet-Fed Murine Model
Mahmoud Omer, Hessein Ali, Nina Orlovskaya, et al.
Page
of 52